Nutritional potassium limitation impact on serum potassium change, and death in chronic kidney disease: A meta-analysis.

Zhumei Gong, Taiai Chen

Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2022;26(6):1079-1085

PMID: 35247229

Abstract

INTRODUCTION

We performed a meta-analysis to evaluate the impact of nutritional potassium limitation on serum potassium change, and death in chronic kidney disease.

METHODS

A systematic literature search up to October 2021 was carried out and eight studies included 92 558 subjects with chronic kidney disease at the start of the study; 41 474 of them were provided with nutritional potassium limitation and 510 084 were nonrestricted diet.

RESULTS

Nutritional potassium limitation had significantly lower serum potassium change (MD, -0.33; 95% CI, -0.58 to -0.07; p = 0.01) compared to nonrestricted diet in subjects with chronic kidney disease. However, nutritional potassium limitation had no significant impact on the death (OR, 0.80; 95% CI, 0.58-1.10; p = 0.17) compared to nonrestricted diet in subjects with chronic kidney disease.

CONCLUSION

Nutritional potassium limitation had significantly lower serum potassium change compared to nonrestricted diet in subjects with chronic kidney disease. Further studies are required to validate these findings.

© 2022 International Society for Apheresis and Japanese Society for Apheresis.

Address: Department of Emergency, Yiwu Central Hospital, Jinhua, China.; Department of Nephrology, Qionghai People's Hospital, Qionghai, China.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.